Background and aims Oral probiotic supplementation may be a beneficial adjunctive
therapy for patients with symptomatic COVID-19. However, its safety and efficacy are …

Background Multi system symptoms such as gastrointestinal tract and respiratory tract exist
in coronavirus disease 2019 (COVID-19) patients. There is a lack of reliable evidence to …

Background Although numerous modalities are currently in use for the treatment and
prophylaxis of COVID-19, probiotics are a cost-effective alternative that could be used in …

The SARS-CoV-2 outbreak has infected a vast population across the world, causing more
than 664 million cases and 6.7 million deaths by January 2023. Vaccination has been …

Objectives This study was conducted to assess the clinical efficacy of probiotics in the
treatment of patients with COVID19. Methods PubMed, Embase, Cochrane Library, and …

The COVID-19 pandemic, caused by the SARS-CoV-2 virus, mainly causes respiratory and
intestinal symptoms and changes in the microbiota of patients. We performed a systematic …

Background: The virus SARS-CoV-2 is responsible for respiratory disorders due to the fact
that it mainly infects the respiratory tract using the Angiotensin-converting enzyme 2 (ACE2) …

Aims Emerging evidence highlights the role of COVID-19 in instigating gut dysbiosis, with
repercussions on disease severity and bidirectional gut-organ communication involving the …

Bifidobacteria as a strictly anaerobic gram-positive bacteria, is widely distributed in the
intestine, vagina and oral cavity, and is one of the first gut flora to colonize the early stages of …

The COVID-19 outbreak has caused significant global changes and increased public
awareness of SARS-CoV-2. Substantial progress in developing vaccines, enhancing …